X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7029) 7029
Book Review (1612) 1612
Publication (424) 424
Book / eBook (56) 56
Book Chapter (38) 38
Dissertation (7) 7
Conference Proceeding (5) 5
Government Document (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6369) 6369
humans (6078) 6078
male (3597) 3597
female (3506) 3506
adult (2520) 2520
middle aged (2501) 2501
oncology (2072) 2072
aged (1885) 1885
surgery (1635) 1635
tumors (1524) 1524
sarcoma (1447) 1447
soft tissue neoplasms - pathology (1445) 1445
adolescent (1278) 1278
pathology (1215) 1215
cancer (1204) 1204
child (1083) 1083
diagnosis, differential (866) 866
soft tissue neoplasms - surgery (861) 861
treatment outcome (851) 851
radiology, nuclear medicine & medical imaging (788) 788
chemotherapy (786) 786
medicine & public health (777) 777
soft tissue neoplasms - diagnosis (772) 772
soft-tissue sarcomas (761) 761
abridged index medicus (750) 750
immunohistochemistry (748) 748
animals (734) 734
diagnosis (719) 719
aged, 80 and over (685) 685
retrospective studies (677) 677
magnetic resonance imaging (674) 674
prognosis (674) 674
soft-tissue sarcoma (653) 653
soft-tissue (613) 613
metastasis (598) 598
sarcoma - pathology (596) 596
child, preschool (580) 580
young adult (571) 571
care and treatment (553) 553
soft tissue sarcoma (504) 504
follow-up studies (500) 500
orthopedics (493) 493
analysis (464) 464
soft tissue neoplasms - diagnostic imaging (460) 460
pediatrics (449) 449
research (430) 430
tomography, x-ray computed (424) 424
combined modality therapy (423) 423
infant (412) 412
soft tissue neoplasms - drug therapy (402) 402
radiotherapy (394) 394
health aspects (388) 388
soft tissue neoplasms - therapy (372) 372
sarcoma - surgery (363) 363
expression (357) 357
sarcoma - drug therapy (357) 357
survival (344) 344
children (334) 334
risk factors (328) 328
patients (316) 316
neoplasm staging (315) 315
hematology (308) 308
soft tissue neoplasms - genetics (305) 305
biopsy (303) 303
bone (303) 303
antineoplastic combined chemotherapy protocols - therapeutic use (295) 295
survival rate (290) 290
tumor (287) 287
bone neoplasms - pathology (280) 280
neoplasms (278) 278
soft tissue neoplasms - metabolism (275) 275
sarcoma - therapy (270) 270
therapy (268) 268
medicine (266) 266
disease-free survival (260) 260
antineoplastic agents - therapeutic use (258) 258
management (257) 257
mice (255) 255
prognostic-factors (243) 243
osteosarcoma (230) 230
metastases (227) 227
time factors (224) 224
biomarkers, tumor - analysis (223) 223
article (222) 222
imaging / radiology (221) 221
reconstructive surgical procedures - methods (220) 220
soft-tissue tumors (219) 219
sarcoma - diagnosis (218) 218
usage (216) 216
rhabdomyosarcoma (215) 215
research article (214) 214
neoplasm metastasis (213) 213
soft tissue neoplasms - blood supply (210) 210
extremities (205) 205
soft tissue (204) 204
carcinoma (203) 203
radiation therapy (202) 202
magnetic resonance imaging - methods (201) 201
hematology, oncology and palliative medicine (198) 198
radiology (198) 198
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Mt Sinai Hospital - Pathology (3) 3
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6878) 6878
German (103) 103
Japanese (31) 31
Russian (26) 26
Chinese (23) 23
French (21) 21
Italian (12) 12
Polish (9) 9
Spanish (9) 9
Portuguese (5) 5
Czech (3) 3
Dutch (2) 2
Serbian (2) 2
Turkish (2) 2
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 12/2007, Volume 13, Issue 23, pp. 7053 - 7058
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2005, Volume 23, Issue 23, pp. 5314 - 5322
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2005, Volume 23, Issue 23, pp. 5323 - 5333
Journal Article
International Journal of Cancer, ISSN 0020-7136, 11/2017, Volume 141, Issue 10, pp. 2112 - 2120
Lipids are known to influence tumour growth, inflammation and chemoresistance. However, the association of circulating lipids with the clinical outcome of... 
castration‐resistant | lipids | prostate cancer | biomarker | prognosis | castration-resistant | CELLS | CERAMIDES | RISK | MECHANISMS | OBESITY | ONCOLOGY | LDL | INSULIN-RESISTANCE | DISEASE | NORMALIZATION | Prognosis | Follow-Up Studies | Soft Tissue Neoplasms - secondary | Prostatic Neoplasms, Castration-Resistant - blood | Humans | Middle Aged | Soft Tissue Neoplasms - blood | Bone Neoplasms - secondary | Soft Tissue Neoplasms - drug therapy | Male | Survival Rate | Lymphatic Metastasis | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostatic Neoplasms, Castration-Resistant - pathology | Biomarkers, Tumor - blood | Neoplasm Grading | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lipids - blood | Aged, 80 and over | Adult | Aged | Bone Neoplasms - drug therapy | Bone Neoplasms - blood | Medical research | Analysis | Medicine, Experimental | Development and progression | Lipids | Liquid chromatography | Metastasis | Prostate cancer | Mass spectrometry | Lecithin | Chemoresistance | Sphingolipids | Clinical outcomes | Subgroups | Metastases | Castration | Modulation | Ceramide | Lipid metabolism | Mass spectroscopy | Metabolism | Patients | Survival | Species classification | Medical prognosis | Sphingomyelin | Metabolic pathways | Prostate | Plasmas (physics) | Cancer | Tumors | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 08/2018, Volume 99, pp. 78 - 85
To investigate the outcome following adjuvant doxorubicin and ifosfamide in a prospective non-randomised study based on a soft tissue sarcoma (STS) patient... 
Growth pattern | Adjuvant treatment | Soft tissue sarcoma | Vascular invasion | Tumour size | Survival | Prognostic factors | Necrosis | METAANALYSIS | CANCER CENTERS | RANDOMIZED CLINICAL-TRIAL | DOXORUBICIN | FOLLOW-UP | IFOSFAMIDE | ONCOLOGY | Doxorubicin - therapeutic use | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Sarcoma - blood supply | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Incidence | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Young Adult | Neoplasm Invasiveness - pathology | Adult | Female | Sarcoma - prevention & control | Soft Tissue Neoplasms - therapy | Ifosfamide - pharmacology | Ifosfamide - therapeutic use | Soft Tissue Neoplasms - mortality | Neoplasm Recurrence, Local - prevention & control | Risk Factors | Treatment Outcome | Soft Tissue Neoplasms - blood supply | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Soft Tissue Neoplasms - pathology | Survival Analysis | Aged | Neoplasm Recurrence, Local - epidemiology | Sarcoma - epidemiology | Doxorubicin - pharmacology | Medical research | Anthracyclines | Sarcoma | Medicine, Experimental | Radiotherapy | Risk factors | Cancer | Slopes | Risk groups | Toxicity | Ifosfamide | Radiation therapy | Risk analysis | Patients | Doxorubicin | Subgroups | Metastases | Confidence intervals | Tissue | Chemotherapy | Medical prognosis | Morphology | Risk assessment | Tumors | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Soft tissue sarcoma; Adjuvant treatment; Prognostic factors; Vascular invasion; Growth pattern; Tumour size; Necrosis; Survival | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 9, pp. 1576 - 1584
In a phase 1/2 trial of immunotherapy using dendritic cells pulsed with autologous tumor lysate and OK‐432, dendritic cell–based immunotherapy activates the... 
clinical trial | tumor lysate | dendritic cells | sarcoma | immunotherapy | CANCER PATIENTS | STAGE IV MELANOMA | CLINICAL-TRIAL | VACCINATION | SUPPORTIVE CARE | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | STREPTOCOCCAL PREPARATION OK-432 | REGULATORY T-CELLS | GENERATION | RELAPSED OSTEOSARCOMA | Interleukin-4 | Immunotherapy - methods | Dendritic Cells | Bone Neoplasms - therapy | Humans | Middle Aged | Male | Leukocytes, Mononuclear | Sarcoma - blood | Sarcoma - therapy | Young Adult | Interleukin-12 - blood | Picibanil | Chondrosarcoma - blood | Adult | Female | Histiocytoma, Malignant Fibrous - therapy | Bone Neoplasms - blood | Child | Osteosarcoma - blood | Soft Tissue Neoplasms - therapy | Leiomyosarcoma - blood | Sarcoma, Clear Cell - blood | Sarcoma, Synovial - therapy | Soft Tissue Neoplasms - blood | Antineoplastic Agents | Treatment Outcome | Chondrosarcoma - therapy | Tumor Necrosis Factor-alpha | Leiomyosarcoma - therapy | Disease-Free Survival | Sarcoma, Synovial - blood | Adolescent | Aged | Histiocytoma, Malignant Fibrous - blood | Sarcoma, Clear Cell - therapy | Granulocyte-Macrophage Colony-Stimulating Factor | Osteosarcoma - therapy | Interferon-gamma - blood | Cancer patients | Usage | Dendritic cells | Immunotherapy | Research | Tumor lysis syndrome | Diagnosis | Health aspects | Therapy | Toxicity | Interleukin | Medical services | Leukocytes (mononuclear) | Macrophages | Metastases | Interleukin 4 | Immunology | Peripheral blood mononuclear cells | Colony-stimulating factor | Cell survival | Immune response | Sarcoma | Granulocyte-macrophage colony-stimulating factor | Soft tissue sarcoma | Interleukin 12 | T cell receptors | Injection | Patients | Side effects | Interferon | Bone | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cancer Imaging, ISSN 1470-7330, 08/2016, Volume 16, Issue 1, pp. 27 - 27
Background: The role of radiolabeled choline (Cho) in patients with biochemical recurrence after radical treatment for prostate cancer (PCa) is well... 
Incidentaloma | Second malignancy | Prostate cancer | F]Choline PET/CT | IMAGE INTERPRETATION | BIOCHEMICAL RECURRENCE | PITFALLS | RADICAL PROSTATECTOMY | C-11-CHOLINE PET/CT | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | [F-18] Choline PET/CT | LYMPHOMA | UPDATE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PSA | Lymph Nodes - pathology | Humans | Bone Neoplasms - secondary | Male | Prostatic Neoplasms - therapy | Rectal Neoplasms - diagnostic imaging | Neoplasms, Second Primary - blood | Lung Neoplasms - secondary | Neoplasm Recurrence, Local - diagnostic imaging | Soft Tissue Neoplasms - diagnostic imaging | Aged, 80 and over | Prostatic Neoplasms - blood | Prostatic Neoplasms - diagnostic imaging | Rectal Neoplasms - secondary | Kallikreins - blood | Bone Neoplasms - blood | Radiopharmaceuticals | Neoplasm Recurrence, Local - blood | Soft Tissue Neoplasms - secondary | Bone Neoplasms - diagnostic imaging | Rectal Neoplasms - blood | Soft Tissue Neoplasms - blood | Prostate-Specific Antigen - blood | Positron Emission Tomography Computed Tomography | Choline | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Aged | Lung Neoplasms - blood | Neoplasms, Second Primary - diagnostic imaging | Complications and side effects | CT imaging | Usage | PET imaging | Metastasis | Diagnosis | Index Medicus
Journal Article
BMC Musculoskeletal Disorders, ISSN 1471-2474, 09/2017, Volume 18, Issue 1, pp. 403 - 403
Background: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by severe hypophosphatemia and osteomalacia. Nonspecific symptoms... 
Hypophosphatemia | Fractures | Fibroblast growth factor 23 | Oncogenic osteomalacia | Phosphaturic mesenchymal tumor | Spontaneous | DIAGNOSIS | PET/CT | RHEUMATOLOGY | OF-THE-LITERATURE | ORTHOPEDICS | Follow-Up Studies | Osteomalacia - diagnostic imaging | Humans | Middle Aged | Osteomalacia - surgery | Male | Neoplasms, Connective Tissue - diagnostic imaging | Soft Tissue Neoplasms - surgery | Soft Tissue Neoplasms - diagnostic imaging | Paraneoplastic Syndromes - surgery | Phosphates - blood | Adult | Female | Retrospective Studies | Hypophosphatemia - surgery | Hypophosphatemia - blood | Soft Tissue Neoplasms - blood | Neoplasms, Connective Tissue - blood | Neoplasms, Connective Tissue - surgery | Treatment Outcome | Osteomalacia - blood | Paraneoplastic Syndromes - blood | Paraneoplastic Syndromes - diagnostic imaging | Hypophosphatemia - diagnostic imaging | Cohort Studies | Soft tissue injuries | Care and treatment | Osteomalacia | Patient outcomes | Risk factors | Femur | Nuclear magnetic resonance--NMR | Mesenchyme | Octreotide | Vertebra | Technetium | Scintigraphy | Pelvis | Metastases | Sacrum | Pain | Computed tomography | Surgery | Fibroblasts | Localization | Growth factors | Urine | Limbs | Medical imaging | Phosphorus | Thorax | Patients | Trauma | Walking | Magnetic resonance imaging | Paraneoplastic syndrome | Positron emission tomography | Tumors | Index Medicus
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 4, pp. 1081 - 1090
Purpose Numerous preclinical studies have demonstrated that angiogenesis inhibitors can increase the efficacy of radiotherapy (RT). We sought to examine the... 
Radiology | Hematology, Oncology and Palliative Medicine | Biomarkers | Angiogenesis inhibitors | Sarcoma | Radiotherapy | Bevacizumab | MICROARRAY | TUMOR RESPONSE | RADIATION | RANDOMIZED TRIAL | RECTAL-CANCER | ONCOLOGY | GROWTH | EXTREMITY | GENE-EXPRESSION | GRADE | PERFUSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Tumor Burden - radiation effects | Humans | Middle Aged | Microvessels - pathology | Male | Gene Expression Profiling | Sarcoma - blood | Sarcoma - therapy | Sarcoma - blood supply | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Angiogenesis Inhibitors - adverse effects | Postoperative Complications | Microvessels - radiation effects | Soft Tissue Neoplasms - therapy | Radiotherapy Dosage | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Neoplasm Recurrence, Local - prevention & control | Microvessels - drug effects | Treatment Outcome | Sarcoma - pathology | Biomarkers, Tumor - blood | Soft Tissue Neoplasms - blood supply | Tumor Burden - drug effects | Neoadjuvant Therapy - adverse effects | Neoadjuvant Therapy - methods | Soft Tissue Neoplasms - pathology | Aged | Cell Proliferation - drug effects | Cell Proliferation - radiation effects | Medical colleges | Radiation | Index Medicus | SURGERY | APOPTOSIS | PATIENTS | BLOOD FLOW | ANGIOGENESIS | CELL PROLIFERATION | TUMOR CELLS | COMPUTERIZED TOMOGRAPHY | SURFACE AREA | NECROSIS | BIOLOGICAL MARKERS | SARCOMAS | GENES | LIVER | RADIOLOGY AND NUCLEAR MEDICINE | PELVIS | RADIOTHERAPY | HYPERTENSION | BLOOD | HAZARDS
Journal Article